Intra-city differences in cardiac expression of inflammatory genes and inflammasomes in young urbanites: A pilot study

Journal of Toxicologic Pathology

Volumn 25, Issue 2, 2012, Pages 163-173

  Villarreal Calderon, Rodolfo ^a   Dale, Gary ^b   Delgado Chávez, Ricardo ^c   Torres Jardón, Ricardo ^d   Zhu, Hongtu ^e   Herritt, Lou ^a   Gónzalez Maciel, Angelica ^f   Reynoso Robles, Rafael ^f   Yuan, Ying ^e   Wang, Jiaping ^e   Solorio López, Edelmira ^f   Medina Cortina, Humberto ^f   Calderón Garcidueñas, Lilian ^a,f  

^a UNIVERSITY OF MONTANA   (United States)

^b Forensic Science Division   (United States)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e University of North Carolina at Chapel Hill   (United States)

^f INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Cardiovascular risk factor; Children; Inflammasomes; Mast cells; Myocardial inflammation; Particulate matter; Urban pollution

Indexed keywords

CASPASE; CD14 ANTIGEN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AIR POLLUTION; AIR QUALITY; ARTICLE; AUTOPSY; CASPASE GENE; CHILD; CLUSTER DESIGNATION ANTIGEN 14 GENE; ELECTRON MICROSCOPY; EPICARDIAL NERVE FIBER; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART RIGHT VENTRICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INTERLEUKIN 10 GENE; INTERLEUKIN 1BETA GENE; MALE; MAST CELL; MYOCARDITIS; NERVE FIBER; NLR FAMILY PYRIN DOMAIN CONTAINING 3 GENE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN NOD CONTAINING 1 GENE; NUCLEOTIDE OLIGOMERIZATION BINDING DOMAIN GENE; PILOT STUDY; REAL TIME POLYMERASE CHAIN REACTION; SUDDEN DEATH; TUMOR NECROSIS FACTOR ALPHA GENE; UNITED STATES; UPREGULATION; URBAN POPULATION;

EID: 84863835727     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.25.163     Document Type: Article

References (64)

1. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr., Whitsel L, and Kaufman JD. Particulate matter air pollution and cardiovascular disease. An update to the scientific statement from the American Heart Association. Circulation. 121: 2331-2378. 2010. [Medline] [CrossRef]
2. Franchini M, and Mannucci PM. Thrombogenicity and cardiovascular effects of ambient air pollution. Blood. 118: 2405-2412. 2011. [Medline] [CrossRef]
3. Bravo-Alvarez HR, and Torres-Jardón RJ. Air pollution levels and trends in the Mexico city metropolitan area. In: Urban Air Pollution and Forests: Resources at Risk in the Mexico City Air Basin Ecological Studies. M Fenn, L Bauer, T Hernández (eds). Vol 156. Springer-Verlag; New York: 121-159. 2002.
4. Molina LT, Madron ich S, Gaffney JS, Apel E, de Foy B, Fast J, Ferrare R, Herndon S, Jimenez JL, Lamb B, Osorio-Vargas AR, Russell P, Schauer JJ, Stevens PS, Volkamer R, and Zavala M. An overview of the MILAGRO 2006 Campaign: Mexico City emissions and their transport and transformation. Atmos Chem Phys. 10: 8697-8760. 2010. [CrossRef]
5. Osornio-Vargas AR, Bonner JC, Alfaro-Moreno E, Martinez L, Garcia-Cuellar C, Ponce-de-Leon-Rosales S, Miranda J, and Rosas I. Proinflammatory and cytotoxic effects of Mexico City air pollution particulate matter in vitro are dependent on particle size and composition. Environ Health Perspect. 111: 1289-1293. 2003. [Medline] [CrossRef]
6. Rosas-Pérez I, Serrano J, Alfaro-Moreno E, Baumgardner D, Garcia-Cuellar C, Martin del campo JM, Raga GB, Castillejos M, Colin RD, and Osornio-Vargas AR. Relations between PM10 c omposition a nd c ell t oxicity: A multivariate and graphical Approach. Chemosphere. 67: 1218-1228. 2007. [Medline]
7. Querol X, Pey J, Minguillón MC, Pérez N, Alastuey A, Viana M, Moreno T, Bernabe RM, Blanco S, Cardenas B, Vega E, Sosa G, Escalona S, Ruiz H, and Artiñano B. PM speciation and sources in Mexico during the MILAGRO- 2006 Campaign. Atmos Chem Phys. 8: 111-128. 2008. [CrossRef]
8. Villarreal-Calderon R, Reed W, Keefe S, Herritt L, Brooks D, Torres-Jardón R, and Calderón-Garcidueñas L. Urban air pollution produces up-regulation of myocardial inflammatory genes and dark chocolate provides cardioprotection. Exp Tox Path. 2010 October 5 E Pub.
9. Garantziotis S, Hollingsworth JW, Zaas AK, and Schwartz DA. The effect of toll-like receptors and toll-like receptors genetics in human disease. Ann Rev Med. 59: 343-359. 2008. [Medline] [CrossRef]
10. Panaro MA, Gagliardi N, Saponaro C, Calvello R, Mitolo I, and Cianciulli A. Toll-like receptor 4 mediates LPSinduced release of nitric oxide and tumor necrosis factoralpha by embryonal cardiomyocytes:biological significance and clinical implications in human pathology. Curr Pharm Des.16: 766-774. 2010. [Medline] [CrossRef]
11. SMA Secretaría del Medio Ambiente del Gobierno del Distrito Federal. Dirección General de Gestión de la Calidad del Aire. Sistema de monitoreo Atmosférico de la ciudad de México. Dirección de Monitoreo Atmosférico. 2008. Indicadores 2010. http://www.sma.df.gob.mx/simat2/.
12. Calderón-Segura ME, Gómez-Arroyo S, Villalobos-Pietrini R, Butterworth FM, and Amador-Munoz O. The effects of seasonal weather on the genotoxicity, cytokinetic properties, cytotoxicity and organochemical content of extracts of airborne particulates in Mexico City. Mutat Res. 558: 7-17. 2004. [Medline]
13. Dzepina K, Arey J, Marr L, Worsnop DR, Salcedo D, Zhang Q, Onasch TB, Molina LT, Molina MJ, and Jimenez JL. Detection of particle-phase polycyclic aromatic hydrocarbons in Mexico City using an aerosol mass spectrometer. International Journal of Mass Spectrometry. 263: 152-170. 2007. [CrossRef]
14. Estrada-Garcia T, Cerna JF, Thompson MR, and López-Saucedo C. Fecal contamination and enterotoxigenic Escherichia coli in street-vended chili sauces in Mexico and its public relevance. Epidemiology and Infection. 129: 223-226. 2002. [Medline] [CrossRef]
15. Riveros-Rosas H, Pfeifer GD, Lynam DR, Pedroza JL, Julian-Sanchez A, Canales O, and Garfias J. Personal exposure to elements in Mexico city air. Sci Total Environ. 198: 79-96. 1997. [Medline] [CrossRef]
16. Stutz A, Golenbock DT, and Latz E. Inflammasomes: too big to miss. J Clin Invest. 119: 3502-3511. 2009. [Medline] [CrossRef]
17. Martinon F, Mayor A, and Tschopp J. The inflammasomes: guardians of the body. Annual Review of Immunology. 27: 229-265. 2009. [Medline] [CrossRef]
18. Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol. 40: 616-619. 2010. [Medline] [CrossRef]
19. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, and Yang XF. Inflammasomes are differentially expressed in cardiovascular and other tissues. International Journal of Immunopathology and Pharmacology. 22: 311-322. 2009. [Medline]
20. Bryant C, and Fitzgerald KA. Molecular mechanisms involved in inflammasome activation. Trends in Cell Biology. 19: 455-464. 2009. [Medline] [CrossRef]
21. Cassel SL, Eisenbarth SC, Iyer SS, and Sadler JJ. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA. 105: 9035-9040. 2008. [Medline] [CrossRef]
22. Dostert C, Petrilli V, van Bruggen R, Steel C, Mossman BT, and Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 320: 674-677. 2008. [Medline] [CrossRef]
23. Hornung V, Bauernfeind F, Halle A, Samstad EO, and Kono H. Silica crystals and aluminum salts activate the NAP3 inflammasome through phagosomal destabilization. Nat Immunol. 9: 847-856. 2008. [Medline] [CrossRef]
24. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, and Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 464: 1357-1361. 2010. [Medline] [CrossRef]
25. Holland MR, Gibson AA, Kirshner CA, Hicks D, Ludomirsky A, and Singh GK. Intrinsic myoarchitectural differences between the left and right ventricles of fetal human hearts: an ultrasonic backscatter feasibility study. Journal of the American Society of Echocardiography. 22: 170-176. 2009. [Medline] [CrossRef]
26. Tverskaya MS, Sukhoparova VV, Karpova VV, Raksha AP, Kadyrova MK, Abdulkerimova NZ, and Bobrova NA. Pathomorphology of myocardial circulation: comparative study in increased left or right ventricle overload. Bulletin of Experimental Biology and Medicine. 145: 377-381. 2008. [Medline] [CrossRef]
27. Bouthillier L, Vincent R, Goegan P, Adamson IY, Bjarnason S, Stewart M, Guénette J, Potvin M, and Kumarathasan P. Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am J Pathol. 153: 1873-1884. 1998. [Medline] [CrossRef]
28. Kang YJ, Li Y, Zhou Z, Roberts AM, Cai L, Myers SR, Wang L, and Schuchke DA. Elevation of serum endothelins and cardiotoxicity induced by particulate matter (PM2.5) in rats with acute myocardial infarction. Cardiovasc Toxicol. 2: 253-261. 2002. [Medline] [CrossRef]
29. Douthwaite JA, Lees DM, and Corder R. A role for in- creased mRNA stability in the induction of endothelin-1 synthesis by lipopolysaccharide. Biochem Pharmacol. 66: 589-594. 2003. [Medline] [CrossRef]
30. Murray DB, Gardner JD, Brower GL, and Janicki JS. Endothelin- 1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol. 287: H2295-2299. 2004. [Medline] [CrossRef]
31. Thomson E, Kumarathasan P, Goegan P, Aubin RA, and Vincent R. Differential regulation of the lung endothelin system by urban particulate matter and ozone. Toxicol Sci. 88: 103-113. 2005. [Medline] [CrossRef]
32. Calderón-Garcidueñas L, Vincent R, Mora-Tiscareño A, Franco-Lira M, Henríquez-Roldán C, Garrido-García L, Camacho-Reyes L, Valencia-Salazar G, Paredes R, Romero L, Osnaya N, Villarreal-Calderon R, Torres-Jardón R, Hazucha MJ, and Reed W. Elevated plasma endothelin-1 and pulmonary arterial pressure in children exposed to air pollution. Environ Health Perspect. 115: 1248-1253. 2007. [Medline] [CrossRef]
33. Deacon K, and Knox AJ. Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cyclic-adenosine mono- phosphate (CAMP) pathways: role of a phospholipase A2(cPLA2)/cyclo-oxygenase-2 (COX-2)/prostacyclin receptor dependent autocrine loop. J Biol Chem. 285: 25913-25927. 2010. [Medline] [CrossRef]
34. Mansart A, Ruff LJ, Arians MP, Ross JJ, Reilly CS, Brown NJ, Kaufman S, and Brookes ZL. Constriction of rat extrasplenic veins to lipopolysaccharide involves endothelin-1. Naunyn Schmiedebergs Arch Pharmacol. 381: 555-562. 2010. [Medline] [CrossRef]
35. Marron K, Wharton J, Sheppard MN, Fagan D, Royston D, Kuhn DM, de Leval MR, Whitehead BF, Anderson RH, and Polak JM. Distribution, morphology, and neurochemistry of endocardial and epicardial nerve terminal arborizations in the human heart. Circulation. 92: 2343-2351. 1995. [Medline]
36. Sola OM, Shi Q, Vernon RB, and Lazzara RR. Cardiac denervation after transmyocardial laser. Ann Thorac Surg. 71: 732. 2001. [Medline]
37. Accord RE, van Suylen RJ, van Brakel TJ, and Maessen JG. Post-mortem histological evaluation of microwave lesions alter epicardial pulmonary vein isolation for atrial fibrillation. Ann Thoracic Surg. 80: 881-887. 2005. [CrossRef]
38. Kulboka A, Lekas R, Veikutis V, Civinskiene G, and Pavilonis A. Changes of cardiac electrophysiological parameters after destruction of pericardial nervous plexi innervating sinoatrial model. Kardiologiia. 45: 11-14. 2005. [Medline]
39. Levick SP, Murray DB, Janicki JS, and Brower GL. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension. 55: 270-276. 2010. [Medline] [CrossRef]
40. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, Cloutheir DE, Yanagisawa MM, Tsai M, Galli SJ. Mast cells promote homeostasis by limiting endothelin- 1-induced toxicity. Nature. 432: 512-516. 2004. [Medline] [CrossRef]
41. Walsh SK, Kane KA, and Wainwright CL. Mast cell degranulation- a mechanism for the anti-arrhythmic effect of endothelin-1? Br J Pharmacol. 157: 716-723. 2009. [Medline] [CrossRef]
42. Eszlári E, Czóbel M, Molnar G, Kaszaki J, Nagy S, and Boros M. Modulation of cardiac contractility through endothelin- 1 release and myocardial mast cell degranulation. Acta Physiol Hung. 95: 267-285. 2008. [Medline] [CrossRef]
43. Calderón-Garcidueñas L, Gambling TM, Acuna H, Garcia R, Osnaya N, Monroy S, Villarreal-Calderon A, Carson J, Koren HS, and Devlin RB. Canines as sentinel species for assessing chronic exposures to air pollutants: part 2. Cardiac pathology. Toxicol Sci. 61: 356-367. 2001. [Medline] [CrossRef]
44. Calderón-Garcidueñas L, Solt AC, Henríquez-Roldán C, Torres-Jardón R, Nuse B, Herritt L, Villarreal-Calderon R, Osnaya N, Garcia R, Brooks DM, Gonzalez-Maciel A, Reynoso-Robles R, Delgado-Chavez R, and Reed W. Longterm air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha- synuclein in children and young adults. Toxicol Pathol. 36: 289-310. 2008. [Medline] [CrossRef]
45. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, and Harken AH. Tumor necrosis factor-alpha and interleukin-1-beta synergistically depress human myocardial function. Critical Care Medicine. 27: 1309-1318. 1999. [Medline] [CrossRef]
46. Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT, and Prabhu SD. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor kappa B and inflammatory activation. Circulation. 119: 1386-1397. 2009. [Medline] [CrossRef]
47. Schulz R, and Heusch G. Tumor necrosis factor-alpha and its receptors 1 and 2. Circulation. 119: 1355-1357. 2009. [Medline] [CrossRef]
48. Schulz R. TNF in myocardial ischemia/reperfusion: Damage vs. protection. Journal of Molecular and Cell Cardiology. 45: 712-714. 2008. [CrossRef]
49. Chen Y, Ke Q, Yang Y, Rana JS, Tang J, Morgan JP, and Xiao YF. Cardiomyocytes overexpressing TNF-alpha attract migration of embryonic stem cells via activation of p38 and c-Jun amino-terminal kinase. FASEB J. 17: 2231-2239. 2003. [Medline] [CrossRef]
50. Bao C, Guo J, Lin G, and Hu Z. TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI. Scandinavian Cardiovascular Journal. 42: 56-62. 2008. [Medline] [CrossRef]
51. Panaro MA, Cianciulli A, Gagliardi N, Mitolo I, Acquafredda A, Cavallo P, and Mitolo V. CD14 major role during lipopolysacchride-induced inflammation in chick embryo cardiomyocytes. Federation European Microbiological Societies Immunology and Medical Microbiology. 53: 35-45. 2008.
52. Fitzgerald KA, Rowe DC, and Golenbock DT. Endotoxin recognition and signal transduction by the TLR4/MD2- complex. Microbes and Infection. 6: 1361-1367. 2004. [Medline] [CrossRef]
53. Rudiger A, and Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Critical Care Medicine. 35: 1599-1608. 2007. [Medline] [CrossRef]
54. Meldrum DR. Tumor necrosis factor in the heart. American Journal of Physiology. 274: R577-R595. 1998 [Medline]
55. Comstock KL, Krown KA, and Page MT. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyo- cytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol. 30: 2761-2775. 1998. [Medline] [CrossRef]
56. Smith BJ, Lightfoot SA, Lerner MR, Denson KD, Morgan DL, Hanas JS, Bronze MS, Postier RG, and Brackett DJ. Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovascular Pathology. 18: 1-10. 2009. [Medline] [CrossRef]
57. Lamkanfi M, and Dixit VM. Inflammasomes: guardians of cytosolic sanctity. Immunological Reviews. 227: 95-105. 2009. [Medline] [CrossRef]
58. Golomb E, Nyska A, and Schwalb H. Occult cardiotoxicitytoxic effects on cardiac ischemic tolerance. Toxicologic Pathology. 37: 572-593. 2009. [Medline] [CrossRef]
59. Mountain DJH, Singh M, and Singh K.Interleukin-1β- mediated inhibition of the processes of angiogenesis in cardiac microvascular endothelial cells. Life Sciences. 82, 1224-1230. 2008. [Medline] [CrossRef]
60. Hwang MW, Matsumori A, Furukawa Y, Ono Y, Okada M, Iwasaki A, Hara M, Miyamoto T, Touma M, and Sasayama S. Neutralization of IL1β in the acute phase of myocardial infarction promotes the promotion of progression of left ventricular remodeling. Journal of American College of Cardiology. 38: 1546-1553. 2001. [CrossRef]
61. Ono K, Matsumori A, Shioi T, Furukawa Y, and Sasayuma S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation. 98: 149-156. 1998. [Medline]
62. Bujak M, and Frangogiannis NG. The role of IL-1 in the pathogenesis of heart disease. Archivum Immunologiae et Therapiae Experimentalis. 57: 165-176. 2009. [Medline] [CrossRef]
63. Brandenberger C, Clift MJD, Vanhecke D, Mühlfeld C, Stone V, Gehr P, and Rothen-Rutishauser B. Intracellular imaging of nanoparticles: Is it an elemental mistake to believe what you see? Part Fibre Toxicol. 7: 15-20. 2010. [Medline] [CrossRef]
64. Nawrot TS, Perez L, Künzli N, Munters E, and Nemery B. Public Health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet. 377: 732-740. 2011. [Medline] [CrossRef]